|View printer-friendly version|
|Array BioPharma To Report Financial Results for the Third Quarter of Fiscal 2004 on May 3, 2004|
BOULDER, Colo.--(BUSINESS WIRE)--April 27, 2004--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the third quarter of fiscal 2004 on Monday, May 3, 2004, at 4:30 p.m. eastern time and hold a conference call on Tuesday, May 4, 2004, at 9:00 a.m. eastern time. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.
CONFERENCE CALL INFORMATION
There will be a replay of the conference call for one week, which can be accessed in the United States by dialing toll-free (888) 203-1112, and outside the United States (719) 457-0820. The access code is 484222. Replay of the call will also be available as a web cast on Array's web site at www.arraybiopharma.com.
Array BioPharma is creating the next generation of orally active drugs by integrating the latest advances in chemistry, biology and informatics. Our drug development pipeline is focused primarily in cancer and inflammatory disease and includes many promising small molecule drugs that affect disease pathways with well-validated targets. Array also collaborates with leading pharmaceutical and biotechnology companies to invent and optimize drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.